PTHS Pelthos Therapeutics Inc.
$14.50▼ -4.61%
Healthcare
Other
Volume 73.2K
Avg Volume (10D) 67.0K
Key Metrics & Fundamentals
Market Cap
$55.51M
P/E Ratio
–
Div Yield
0.00%
52W Range
14.44 - 37.50
% vs 50 MA
-34.38%
% vs 200 MA
-40.48%
RSI-14
23.4
MACD Histogram
-0.4600
Beta (1Y vs SPY)
0.31
Free Cash Flow
-$7.67M
Gross Rev
$15.60M
Gross Profit
$2.77M
EBITDA
-$19.71M
COGS
$12.83M
Operating Exp
$20.10M
Operating Income
-$17.32M
EBIT
-$17.32M
Pretax Income
-$23.42M
Net Income
-$23.42M
EPS (Diluted)
-6.62
Price & Volume History
Loading chart…
Recent News
Pelthos Therapeutics (PTHS) Stock Fair Value Falls After Analysts Cut Zelsuvmi Launch Estimates
Simply Wall St. · Oct 13, 2026 10:14 PM ET
Pelthos Therapeutics Announces Expanded Formulary Coverage for ZELSUVMI® (berdazimer) Topical Gel, 10.3%
GlobeNewswire · Oct 6, 2026 8:00 AM ET
Pelthos (PTHS) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 20, 2026 9:04 AM ET
Pelthos Therapeutics Q2 Earnings Call Highlights
MarketBeat · Aug 14, 2026 4:04 AM ET
Pelthos Therapeutics Inc (PTHS) (Q2 2026) Earnings Call Highlights: Revenue Surges 45% as ...
GuruFocus.com · Aug 13, 2026 7:06 PM ET
Pelthos Therapeutics Inc. Q2 2026 Earnings Call Summary
Moby · Aug 13, 2026 5:05 PM ET
Pelthos Therapeutics Inc. (PTHS) Reports Q2 Loss, Lags Revenue Estimates
Zacks · Aug 13, 2026 8:25 AM ET
Pelthos Therapeutics Announces Second Quarter 2026 Financial Results
GlobeNewswire · Aug 13, 2026 7:10 AM ET
Earnings To Watch: Pelthos Therapeutics Inc (PTHS) Reports Q2 2026 Result
GuruFocus.com · Aug 12, 2026 9:29 AM ET
This Biotech Dealmaker — Tied To Merck, Travere — Is In A Profit-Taking Zone
Investor's Business Daily · Aug 6, 2026 4:08 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See PTHS's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.